BioCentury
ARTICLE | Company News

Kotobuki, Shionogi in deal for cholesterol absorption inhibitor

October 2, 2012 1:29 AM UTC

Kotobuki Pharmaceutical Co. (Tokyo, Japan) granted Shionogi & Co. Ltd. (Osaka, Japan) worldwide rights to develop and commercialize cholesterol absorption inhibitor KT6-971. Kotobuki will receive an u...